Insiders / Protopapas Anna

Protopapas Anna

CIK 1347582personinsider
Companies
2
First seen
Jan 6, 2026
Last activity
Jun 18, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Nuvalent, Inc. · NUVLDirector8,5908,5901
Mersana Therapeutics, Inc. · MRSNDirector0020

All securities held

1 position · latest reported per filing
CompanySecuritySharesAs of
Nuvalent, Inc.Class A Common Stock8,590Jun 16, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jun 16, 2026GrantNUVL
Nuvalent, Inc.
Class A Common Stock
$0+3K
+66.93%
8,590
0.01% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-166
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-5K
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-1K
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-2K
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-11K
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-9K
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-665
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-12K
-100.00%
0
0.00% of shares
low
Jan 6, 2026OtherMRSN
Mersana Therapeutics, Inc.
Stock Option (right to buy)
-988
-100.00%
0
0.00% of shares
low